Mint."The current data pertaining to the trials show that there are no immediate concerns pertaining to Covishield," Poonawalla added. "So far, thousands of people have had it in India and abroad with no safety concerns," he further explained.
However it will take two to three years to ascertain the long-term effects of the vaccine, he said. The COVID-19 vaccine, developed by the University of Oxford in collaboration with AstraZeneca, is one of the most advanced candidates in the race against the novel coronavirus.
The recombinant viral vector vaccine produce a immune response in both old and young adults, showed data released in October.